(+)-2-methylpiperidine as modulator of cholinergic systems
US5272155A · kind A · utility
1Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 5, 1991 |
| Grant date | Dec 21, 1993 |
| Priority date | — |
| Expiry date | Dec 5, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/465
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions comprising a therapeutically effective amount of (+) 2-methylpiperidine and a pharmaceutically-acceptable carrier or diluent, as well as to a method of treating cognitive, neurological and mental disorders, which are characterized by decreased cholinergic function in humans and lower mammals, by administration of (+)2-methylpiperidine, optionally with a nicotinic agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.